Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
D000956:Antigens, Viral; D002213:Capsid / Q000276:immunology; D002460:Cell Line; D002472:Cell Transformation, Viral / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D017245:Foscarnet; D004854:Herpesvirus 4, Human / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects*; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000494:pharmacology*
D000956:Antigens, Viral; D009943:Organophosphorus Compounds; C024245:ethyl diethyl-phosphonoformate; D017245:Foscarnet; D010746:Phosphonoacetic Acid